ClinPhone, the UK-based clinical technology specialist whose shares have taken a battering recently on a profit warning and a £10 million cut in its annual revenue forecast, had some more upbeat news to deliver as it announced a preferred supplier contract with Bayer Yakuhin, the Japanese affiliate of Bayer Schering Pharma.
The UK company will supply Bayer Yakuhin with randomisation and trial supply management services powered by Interactive Voice Response (IVR) technology for a key Phase III trial taking place in Japan, it said. ClinPhone already provides technology solutions to a number of major Japanese clients globally but this project represents “a major expansion into the Japanese market itself”, it noted.
The deal came on the back of ClinPhone opening its first office serving the Asia-Pacific region in Melbourne, Australia, last October.
“The location of the offices in Melbourne means that ClinPhone is able to provide a more consultative service across the Asia Pacific,” commented Kevin Wightman, business development director, Asia Pacific region. “The availability of business, technical and operational expertise in Asian business hours will really complement our established 24/7 global service and enable us to focus on the needs of our customers as we continue to strengthen our presence in the region.”